Asegua Therapeutics LLC is recalling 18,541 cartons of Sofosbuvir and Velpatasvir (400 mg/100 mg) tablets because the blister packs may not be properly sealed. This defect results in tablets being loose within the carton instead of protected in their individual blister slots. The recall affects one specific lot of 28-count cartons (2x14 blister cards) manufactured for Asegua Therapeutics LLC, an affiliate of Gilead Sciences, Inc.
Blister packs that are not properly sealed can expose the medication to air and moisture, which may degrade the tablets and reduce their effectiveness. Additionally, tablets being loose in the carton increases the risk of the pills being damaged, lost, or potentially contaminated.
You have 2 options:
Manufactured for Asegua Therapeutics LLC (an affiliate of Gilead Sciences, Inc.) and made in Ireland.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.